₹18.5
▼ -1.2 -6.09%
17 Jul 2026
NSE Listed
Aatmaj Healthcare Limited (AATMAJ)
Volume: 4,000Avg Vol 1W: 2,800Avg Vol 1M: 3,70052W Range:₹16.95₹25.5
Key Ratios
Checked 10h agoMarket Cap₹45 Cr
Current Price₹18.5
Previous Close₹19.7
High / Low (52w)₹25.5 / ₹16.95
Volume4,000
Avg Vol (1W)2,800
Avg Vol (1M)3,700
Stock P/E246.25
Book Value₹22.49
Dividend Yield0%
ROE140.3%
ROA—
Revenue (TTM)₹21 Cr
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹0.32
P/B0.88
Debt / Equity0.16
50 DMA₹19.84
200 DMA₹20.67
Day change-6.09%
Price Chart
₹18.5▼ 8.42% · 1Y
2025-07-172026-07-16
20-day avg volume: 4K shares
Pros
- Healthy return on equity of 140.3%.
- Company is almost debt-free.
- Stock trades below its book value.
Cons
- Revenue fell 26% YoY.
- Company is loss-making at the latest annual result.
- Stock trades at a high P/E of 246.
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹3 Cr | ₹4 Cr | ₹17 Cr | ₹22 Cr | ₹27 Cr | ₹17 Cr | ₹21 Cr |
| EBITDA | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹7 Cr | ₹9 Cr | ₹3 Cr | ₹2 Cr |
| Net Profit | ₹-1 Cr | ₹0 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr | ₹1 Cr | ₹1 Cr |
| EPS | -1.62 | -0.5 | 7.63 | 37.41 | 3.64 | 0.39 | 0.28 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹11 Cr | ₹9 Cr | ₹10 Cr | ₹17 Cr | ₹31 Cr | ₹58 Cr | ₹63 Cr |
| Total Liabilities | ₹10 Cr | ₹10 Cr | ₹7 Cr | ₹9 Cr | ₹17 Cr | ₹8 Cr | ₹13 Cr |
| Equity | ₹1 Cr | ₹-1 Cr | ₹3 Cr | ₹8 Cr | ₹14 Cr | ₹49 Cr | ₹50 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹6 Cr | ₹8 Cr | ₹3 Cr | ₹-8 Cr | ₹3 Cr |
| Investing | ₹-1 Cr | ₹-3 Cr | ₹-1 Cr | ₹-8 Cr | ₹-1 Cr |
| Financing | ₹-5 Cr | ₹-7 Cr | ₹-4 Cr | ₹26 Cr | ₹-1 Cr |
| Free Cash Flow | ₹6 Cr | ₹8 Cr | ₹3 Cr | ₹-8 Cr | ₹3 Cr |
Shareholding
Promoter 64.33% Institutions 0% Public 35.67%
Efficiency & Working Capital
ROCE3.3%
Interest Coverage2.2
Dividend Payout—
Debtor Days459 d
Inventory Days13 d
Payable Days27 d
Cash Conversion Cycle445 d
Working Capital Days473 d
Shareholding Details
As of 2026-03-31
Promoter64.3%
FII0%
DII0%
Institutions0%
Public35.7%
Promoter Pledge0%
No. of Shareholders1,288
Shareholding Pattern
Quarterly — figures in %. Latest 9 quarters.
| Period | Mar 2023 | Jun 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 88.9% | 63.7% | 63.7% | 63.7% | 63.7% | 63.7% | 63.7% | 63.8% | 64.3% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 11.1% | 36.3% | 36.3% | 36.3% | 36.3% | 36.3% | 36.3% | 36.2% | 35.7% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 9 | 2,511 | 1,772 | 1,537 | 1,522 | 1,409 | 1,389 | 1,350 | 1,288 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Tushar Karshanbhai Suvagiya | Shareholding of Promoter and Promoter Group | 46.7% | 1.06 Cr |
| Neomile Corporate Advisory Limited | Public Shareholding | 4.6% | 10,30,000 |
| Jignasa Tusharbhai Suvagiya | Shareholding of Promoter and Promoter Group | 4.1% | 9,24,000 |
| Jayshree Sanjay Kolambekar | Public Shareholding | 4% | 9,02,000 |
| Jitesh Narshibhai Suvagiya | Public Shareholding | 4% | 9,00,000 |
| Karshanbhai Jethabhai Suvagiya | Shareholding of Promoter and Promoter Group | 4% | 9,00,000 |
| Suvagiya Jayaben Karsanbhai | Shareholding of Promoter and Promoter Group | 4% | 9,00,000 |
| Ripal Subhash Padmani | Shareholding of Promoter and Promoter Group | 2% | 4,50,000 |
| Subhash Padmani | Shareholding of Promoter and Promoter Group | 2% | 4,50,000 |
| Ravi Arvind Apte | Shareholding of Promoter and Promoter Group | 1.6% | 3,60,000 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Tushar Karshanbhai Suvagiya | 0 | 0% | 2026-03-31 |
| Jignasa Tusharbhai Suvagiya | 0 | 0% | 2026-03-31 |
| Karshanbhai Jethabhai Suvagiya | 0 | 0% | 2026-03-31 |
| Suvagiya Jayaben Karsanbhai | 0 | 0% | 2026-03-31 |
| Ripal Subhash Padmani | 0 | 0% | 2026-03-31 |
| Subhash Padmani | 0 | 0% | 2026-03-31 |
| Ravi Arvind Apte | 0 | 0% | 2026-03-31 |
| Jayshree Sanjay Kolambekar | 0 | 0% | 2026-03-31 |
| Jitesh Narshibhai Suvagiya | 0 | 0% | 2026-03-31 |
| Neomile Corporate Advisory Limited | 0 | 0% | 2026-03-31 |
| Tushar Karshanbhai Suvagiya | 0 | 0% | 2025-09-30 |
| Jignasa Tusharbhai Suvagiya | 0 | 0% | 2025-09-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Tushar Suvagiya | Managing Director | 2025 |
| Jignasa Suvagiya | Whole-time Director | 2025 |
| Ravi Apte | Non Executive Director | 2025 |
| Jigneshkumar Gandhi | Independent Non Exe. Director | 2025 |
| Nirajkumar Lila | Independent Non Exe. Director | 2025 |
| Mansukh Patel | Independent Non Exe. Director | 2025 |
| Poorvi Gattani | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹5 | 12 | 11 | 11 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 10 | 0 | 10 |
| 2025 | 0 | 0 | 0 | 7 | 0 | 7 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
🌐 www.jupiterhospitalvadodara.com ↗
📍 JupiterHospital OppICAI Bhavan, Sunpharma Ataladra Road, Vadodara, Gujarat, 390012
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search